Loading...
Ticagrelor: molecular discovery to clinical evidence: Ticagrelor: a novel antiplatelet agent
Cardiovascular (CV) deaths are one of the leading cause of death, both in developed and developing countries, with acute coronary syndrome (ACS) accounting for about 50% of all CV deaths. Atherothrombosis formation is the prime reason behind ACS and platelets play a central role in formation of thro...
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elsevier
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3861097/ https://ncbi.nlm.nih.gov/pubmed/23102389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2012.09.002 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|